The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences - March 2024 | WilmerHale : vimarsana.com

Calls for Removal of Device Patents Listed in the Orange Book Continue. FTC and Congressional action scrutinizing allegedly “improper” Orange Book listings continued apace in the first...

Related Keywords

Vermont , United States , State Of New York , New York , California , North Carolina , New Jersey , Amy Klobuchar , Amneal Pharms , Elizabeth Warren , Pramila Jayapal , Tech Inc , Court Allows Claims To Proceed Against Teva , Mission Health Antitrust Litigation , Teva Pharmaceutical Industries Ltd , York Supreme Court Justice Robertr Reed , Mission Health Systems , Pharmacy Inc , Boehringer Ingelheim , Supreme Court , Court Dismisses Ny Ag Drug Rebate Tying , Astrazeneca , Cipla , D Inc , Cipla United States Inc , Device Patents Listed , Orange Book , Policy Statement , Senator Elizabeth Warren , Representative Pramila Jayapal , Senator Amy Klobuchar , Senator Klobuchar , While Cipla , Teva Branded , Allows Claims , Proceed Against Teva , Allegedly Delaying Copaxone Generic , Sherman Act , Blue Cross , Blue Shield , Pharmaceutical Industries , Grants Summary Judgment , Invisalign Antitrust , Northern District , Align Technology , Smile Direct Club , Dismiss Monopoly Claims Against Two Hospital , Western District , Western North , Rebate Tying Claims , New York Supreme Court Justice Robert , New York Attorney General ,